Last updated 39 days ago

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

711 patients around the world
Available in Panama, Spain, United States, Mexico, Argentina, Brazil
GlaxoSmithKline
4Research sites
711Patients around the world
This study is for people with
Colorectal cancer
Colon cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Sanatorio de la Mujer - Rosario
Recruiting
San Luis 2493, Rosario, Santa Fe
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Av. Crámer 1180, CABA, Buenos Aires
Fundación Favaloro para la Docencia e Investigación Médica - CABA, Buenos Aires
Recruiting
Av. Belgrano 1782, CABA, Buenos Aires
Sanatorio Médico de Diagnóstico y Tratamiento SA
Recruiting
25 de mayo 3240, Rosario, Santa Fe
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy